馃拤 TD Cowen kept a Hold rating on Merck despite Wednesday鈥檚 news that its cancer vaccine succeeded in a large clinical trial, tempering some of this week鈥檚 pharma optimism.
馃拤 TD Cowen kept a Hold rating on Merck despite Wednesday鈥檚 news that its cancer vaccine succeeded in a large clinical trial, tempering some of this week鈥檚 pharma optimism.